Allianz SE Acquires 3,415 Shares of Intuitive Surgical, Inc. $ISRG

Allianz SE grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.7% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 20,780 shares of the medical equipment provider’s stock after buying an additional 3,415 shares during the period. Allianz SE’s holdings in Intuitive Surgical were worth $11,292,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Larson Financial Group LLC grew its position in shares of Intuitive Surgical by 8.8% during the 1st quarter. Larson Financial Group LLC now owns 4,456 shares of the medical equipment provider’s stock worth $2,207,000 after buying an additional 359 shares during the period. Bridgewater Advisors Inc. acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $459,000. DDD Partners LLC bought a new position in Intuitive Surgical in the first quarter valued at approximately $318,000. Finally, Cullen Frost Bankers Inc. raised its stake in shares of Intuitive Surgical by 1.8% in the 1st quarter. Cullen Frost Bankers Inc. now owns 77,382 shares of the medical equipment provider’s stock valued at $38,325,000 after purchasing an additional 1,387 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Rothschild & Co Redburn lifted their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Trading Up 0.0%

NASDAQ ISRG opened at $572.45 on Thursday. The firm has a market capitalization of $205.21 billion, a P/E ratio of 75.72, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The business has a fifty day simple moving average of $478.64 and a 200 day simple moving average of $502.49.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the business earned $1.84 EPS. The company’s revenue was up 22.9% compared to the same quarter last year. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, Director Craig H. Barratt sold 2,193 shares of the business’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 101,683 shares of company stock worth $53,517,192. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.